[ORGANIZATION]
ifinatamab deruxtecan
Featured in 1 tracked story · first seen
Also covered in
-
Daiichi Sankyo and Merck withdraw lung cancer drug application
[HEALTH] · 2 sources ·
[ORGANIZATION]
Featured in 1 tracked story · first seen
[HEALTH] · 2 sources ·